{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:30:17Z","timestamp":1790656217479,"version":"4.1.0"},"reference-count":255,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T00:00:00Z","timestamp":1451433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143080","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T13:52:08Z","timestamp":1451483528000},"page":"e0143080","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":238,"title":["C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review"],"prefix":"10.1371","volume":"10","author":[{"given":"Shiva","family":"Shrotriya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Bennani-Baiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona","family":"Lorton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"ref1"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ewjm.172.5.310","article-title":"Extent and determinants of error in physicians&apos; prognoses in terminally ill patients: prospective cohort study","volume":"172","author":"NA Christakis","year":"2000","journal-title":"West J Med"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/jpm.2008.9992","article-title":"Palliative medicine review: prognostication","volume":"11","author":"PA Glare","year":"2008","journal-title":"J Palliat Med"},{"issue":"14","key":"ref4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/jnci\/dji193","article-title":"Identification of clinically useful cancer prognostic factors: what are we missing?","volume":"97","author":"LM McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1749-6632.1982.tb22153.x","article-title":"Serum C-reactive protein levels in disease","volume":"389","author":"JJ Morley","year":"1982","journal-title":"Ann N Y Acad Sci"},{"issue":"47","key":"ref6","doi-asserted-by":"crossref","first-page":"48487","DOI":"10.1074\/jbc.R400025200","article-title":"C-reactive Protein","volume":"279","author":"S Black","year":"2004","journal-title":"J Biol Chem"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"MB Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"ref8","article-title":"Cytokines in Human Health","author":"T Whiteside","year":"2007"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00296-007-0357-y","article-title":"Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis","volume":"27","author":"P Emery","year":"2007","journal-title":"Rheumatol Int"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3949\/ccjm.70.7.634","article-title":"Using C-reactive protein to assess cardiovascular disease risk","volume":"70","author":"MH Shishehbor","year":"2003","journal-title":"Cleve Clin J Med"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.CIR.0000120707.98922.E3","article-title":"C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany","volume":"109","author":"W Koenig","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archinte.162.8.867","article-title":"Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk?","volume":"162","author":"I Kushner","year":"2002","journal-title":"Arch Intern Med"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bcp.2006.06.029","article-title":"Inflammation and cancer: how hot is the link?","volume":"72","author":"BB Aggarwal","year":"2006","journal-title":"Biochem Pharmacol"},{"issue":"6917","key":"ref14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"LM Coussens","year":"2002","journal-title":"Nature"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/cncr.11382","article-title":"Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms","volume":"97","author":"CS Cleeland","year":"2003","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/cs0960083","article-title":"Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumor necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer","volume":"96","author":"MD Barber","year":"1999","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11912-002-0023-1","article-title":"The role of C-reactive protein as a prognostic indicator in advanced cancer","volume":"4","author":"FA Mahmoud","year":"2002","journal-title":"Curr Oncol Rep"},{"key":"ref18","first-page":"5","article-title":"Conducting a review, stage II: PHASE 5: study quality assessment","author":"K Khan","year":"2001","journal-title":"Undertaking systematic reviews of research on effectiveness: CRD\u2019s guidance for those carrying out or commissioning reviews (CRD Report 4, 2nd ed) Centre for Reviews and Dissemination"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/082585970702300205","article-title":"A systematic review of prognostic tools for estimating survival time in palliative care","volume":"23","author":"F Lau","year":"2007","journal-title":"J Palliat Care"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"D Moher","year":"2010","journal-title":"International journal of surgery (London, England)"},{"issue":"3","key":"ref22","first-page":"301","article-title":"Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma","volume":"19","author":"M Deichmann","year":"2000","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.bjc.6602043","article-title":"Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase","volume":"91","author":"M Deichmann","year":"2004","journal-title":"Br J Cancer"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jcla.21486","article-title":"Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus)","volume":"26","author":"M Lukaszewicz-Zajac","year":"2012","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/JTO.0b013e318244ffe1","article-title":"Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer","volume":"7","author":"EY Leung","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2168.2001.01669.x","article-title":"Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer","volume":"88","author":"SJ Wigmore","year":"2001","journal-title":"Br J Surg"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s11605-009-1113-2","article-title":"Association of C-reactive protein levels and long-term survival after neoadjuvant therapy and esophagectomy for esophageal cancer","volume":"14","author":"U Zingg","year":"2010","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/1097-0142(19951015)76:8<1435::AID-CNCR2820760821>3.0.CO;2-Y","article-title":"Serum acute phase reactants and prognosis in renal cell carcinoma","volume":"76","author":"B Ljungberg","year":"1995","journal-title":"Cancer"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1442-2042.1997.tb00181.x","article-title":"Prognostic factors for renal cell carcinoma: a multivariate analysis of 320 cases","volume":"4","author":"H Masuda","year":"1997","journal-title":"Int J Urol"},{"issue":"4","key":"ref30","first-page":"229","article-title":"Multivariate analysis of prognostic determinants after surgery for renal cell carcinoma at Himeji National Hospital","volume":"46","author":"T Inoue","year":"2000","journal-title":"Hinyokika Kiyo"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-4295(01)01165-7","article-title":"Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma","volume":"58","author":"Y Miyata","year":"2001","journal-title":"Urology"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/jjco\/hyp068","article-title":"Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens","volume":"39","author":"K Ito","year":"2009","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1442-2042.2008.02017.x","article-title":"Prognostic factors of renal cell carcinoma with extension into inferior vena cava","volume":"15","author":"M Tanaka","year":"2008","journal-title":"Int J Urol"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6605720","article-title":"Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer","volume":"103","author":"SL Wood","year":"2010","journal-title":"Br J Cancer"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1111\/j.1464-410X.2010.09817.x","article-title":"C-reactive protein is a strong predictor for anaemia in renal cell carcinoma: role of IL-6 in overall survival","volume":"107","author":"CE Falkensammer","year":"2011","journal-title":"BJU Int"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.juro.2011.06.014","article-title":"Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma","volume":"186","author":"TV Johnson","year":"2011","journal-title":"J Urol"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF03256414","article-title":"Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma","volume":"15","author":"A Michigan","year":"2011","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"ref38","first-page":"3045","article-title":"Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma","volume":"22","author":"E Naglieri","year":"2002","journal-title":"Anticancer Res"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0360-3016(00)00783-5","article-title":"Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis","volume":"49","author":"A Inoue","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/bjc.1992.433","article-title":"Interleukin 2 therapy in cancer: identification of responders","volume":"66","author":"J Broom","year":"1992","journal-title":"Br J Cancer"},{"issue":"12","key":"ref41","first-page":"3317","article-title":"Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma","volume":"52","author":"JY Blay","year":"1992","journal-title":"Cancer Res"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0022-5347(05)68072-X","article-title":"Serum C-reactive protein level and the impact of cytoreductive surgery in patients with metastatic renal cell carcinoma","volume":"162","author":"K Fujikawa","year":"1999","journal-title":"J Urol"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.bjc.6600768","article-title":"Metastatic renal carcinoma comprehensive prognostic system","volume":"88","author":"J Atzpodien","year":"2003","journal-title":"Br J Cancer"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/sj.bjc.6602152","article-title":"The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer","volume":"91","author":"E Bromwich","year":"2004","journal-title":"Br J Cancer"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.ju.0000146713.50673.e5","article-title":"C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy","volume":"173","author":"A Casamassima","year":"2005","journal-title":"J Urol"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.21477","article-title":"Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation","volume":"104","author":"J Peccatori","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bjc.6603327","article-title":"Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable","volume":"95","author":"UM Vogl","year":"2006","journal-title":"Br J Cancer"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.bjc.6605973","article-title":"Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein","volume":"103","author":"SP Jagdev","year":"2010","journal-title":"Br J Cancer"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"766 e1","DOI":"10.1016\/j.urology.2010.01.052","article-title":"Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma","volume":"76","author":"TV Johnson","year":"2010","journal-title":"Urology"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1464-410X.2007.07363.x","article-title":"Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer","volume":"101","author":"S Ramsey","year":"2008","journal-title":"BJU Int"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1464-410X.2008.07666.x","article-title":"The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer","volume":"102","author":"GW Lamb","year":"2008","journal-title":"BJU Int"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1442-2042.2006.01563.x","article-title":"Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma","volume":"13","author":"K Ito","year":"2006","journal-title":"Int J Urol"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.juro.2009.10.014","article-title":"Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma","volume":"183","author":"TV Johnson","year":"2010","journal-title":"J Urol"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4111\/kju.2011.52.2.104","article-title":"Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma","volume":"52","author":"DS Cho","year":"2011","journal-title":"Korean J Urol"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2011.03.113","article-title":"Impact of postoperative C-reactive protein level on recurrence and prognosis in patients with N0M0 clear cell renal cell carcinoma","volume":"186","author":"K Ito","year":"2011","journal-title":"J Urol"},{"issue":"11","key":"ref56","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s00432-011-1040-y","article-title":"Characteristics of aggressive variants in T1a renal cell carcinoma","volume":"137","author":"T Takayama","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"ref57","first-page":"136","article-title":"The role of acute-phase reactant proteins, carcinoembryonic antigen and CA 19\u20139 as a marker in the preoperative staging of colorectal cancer: a prospective clinical study","volume":"81","author":"S Yuceyar","year":"1996","journal-title":"Int Surg"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2407-10-203","article-title":"Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer","volume":"10","author":"KA Kwon","year":"2010","journal-title":"BMC Cancer"},{"issue":"4","key":"ref59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/02841869409098438","article-title":"Host markers and prognosis in recurrent rectal carcinomas treated with radiotherapy","volume":"33","author":"E Hannisdal","year":"1994","journal-title":"Acta Oncol"},{"issue":"54","key":"ref60","first-page":"1910","article-title":"Significance of inflammatory cytokines in the progression of colorectal cancer","volume":"50","author":"YC Chung","year":"2003","journal-title":"Hepatogastroenterology"},{"issue":"8","key":"ref61","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/bjs.5706","article-title":"Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer","volume":"94","author":"JE Crozier","year":"2007","journal-title":"Br J Surg"},{"issue":"12","key":"ref62","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1111\/j.1440-1746.2006.04792.x","article-title":"Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer","volume":"22","author":"JE Crozier","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"ref63","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00384-011-1187-7","article-title":"C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin","volume":"26","author":"MC van de Poll","year":"2011","journal-title":"Int J Colorectal Dis"},{"issue":"7","key":"ref64","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/0284186X.2012.705020","article-title":"Evaluation of predictive markers for patients with advanced colorectal cancer","volume":"51","author":"P Bystrom","year":"2012","journal-title":"Acta Oncol"},{"issue":"5","key":"ref65","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3892\/etm.2011.308","article-title":"Prognostic value of an inflammation-based score in patients undergoing pre-operative chemotherapy followed by surgery for esophageal cancer","volume":"2","author":"H Miyata","year":"2011","journal-title":"Exp Ther Med"},{"issue":"8","key":"ref66","first-page":"3291","article-title":"Clinical significance of tumor pathology for postoperative survival of patients undergoing surgery for stage IV colorectal cancer","volume":"32","author":"M Ishizuka","year":"2012","journal-title":"Anticancer Res"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00042737-200304000-00006","article-title":"Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator","volume":"15","author":"YC Chung","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8 Pt 1","key":"ref68","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1440-1746.2006.04734.x","article-title":"Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine","volume":"23","author":"A Sawaki","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"ref69","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jjco\/hyn098","article-title":"Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy","volume":"38","author":"T Tanaka","year":"2008","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"ref70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13277-010-0044-6","article-title":"Prognostic relevance of CA 19\u20139, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer","volume":"31","author":"M Haas","year":"2010","journal-title":"Tumour Biol"},{"issue":"9","key":"ref71","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1245\/s10434-012-2348-9","article-title":"The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma","volume":"19","author":"M La Torre","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"5\u20136","key":"ref72","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000323486","article-title":"Clinical significance of pretreatment C-reactive protein in patients with advanced nonsquamous, non-small cell lung cancer who received gefitinib","volume":"79","author":"K Masago","year":"2010","journal-title":"Oncology"},{"issue":"2","key":"ref73","first-page":"85","article-title":"Postoperative serum C-reactive protein levels in non-small cell lung cancer patients","volume":"16","author":"M Hara","year":"2010","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.lungcan.2012.04.008","article-title":"The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer","volume":"77","author":"I Gioulbasanis","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"ref75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amjsurg.2010.09.030","article-title":"Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients","volume":"203","author":"M Ishizuka","year":"2012","journal-title":"Am J Surg"},{"issue":"5","key":"ref76","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2012.06.022","article-title":"A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI)","volume":"57","author":"DJ Pinato","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"ref77","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1007\/s12032-012-0220-1","article-title":"Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma","volume":"29","author":"A Kinoshita","year":"2012","journal-title":"Med Oncol"},{"issue":"5","key":"ref78","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1200\/JCO.1996.14.5.1697","article-title":"Predictors of clinical response to interleukin-2\u2014based immunotherapy in melanoma patients: a French multiinstitutional study","volume":"14","author":"E Tartour","year":"1996","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref79","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/bcr2891","article-title":"Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study","volume":"13","author":"KH Allin","year":"2011","journal-title":"Breast Cancer Res"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7819-9-18","article-title":"Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients","volume":"9","author":"P Ravishankaran","year":"2011","journal-title":"World J Surg Oncol"},{"issue":"2","key":"ref81","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5173\/ceju.2012.02.art1","article-title":"Serum C-reactive protein level is significant prognostic indicator in patients with advanced urothelial cancer treated with Gemcitabine-Cisplatin or Carboplatin-preliminary results","volume":"65","author":"S Morizane","year":"2012","journal-title":"Central European Journal of Urology"},{"key":"ref82","article-title":"C-reactive protein: A biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy","author":"J Obata","year":"2012","journal-title":"Urol Oncol"},{"issue":"8","key":"ref83","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1464-410X.2007.07408.x","article-title":"C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy","volume":"101","author":"S Yoshida","year":"2008","journal-title":"BJU Int"},{"issue":"11","key":"ref84","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/cncr.23461","article-title":"C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial","volume":"112","author":"TM Beer","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"ref85","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.urology.2011.07.1416","article-title":"Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel","volume":"78","author":"M Ito","year":"2011","journal-title":"Urology"},{"issue":"2","key":"ref86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/pcan.2011.60","article-title":"Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study","volume":"15","author":"K Shafique","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"ref87","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2007.06.001","article-title":"C-reactive protein is a prognostic parameter in patients with cervical cancer","volume":"107","author":"S Polterauer","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"ref88","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1158\/1078-0432.CCR-07-1044","article-title":"Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer","volume":"14","author":"LA Hefler","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ref89","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/cncr.26353","article-title":"Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma","volume":"118","author":"T Nakamura","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"ref90","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0301-2115(98)00227-9","article-title":"Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer","volume":"82","author":"J Kodama","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"ref91","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1349-7006.1996.tb03145.x","article-title":"Prognostic value of the doubling time of serum C-reactive protein and alkaline phosphatase levels in primary bone and soft tissue tumors","volume":"87","author":"K Yudoh","year":"1996","journal-title":"Jpn J Cancer Res"},{"issue":"13","key":"ref92","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2008.19.8440","article-title":"Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer","volume":"27","author":"KH Allin","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref93","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1538-7836.2010.04069.x","article-title":"Thrombosis risk and survival in cancer patients with elevated C-reactive protein","volume":"9","author":"R Kanz","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"6","key":"ref94","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jpainsymman.2009.09.021","article-title":"Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report","volume":"39","author":"E Del Fabbro","year":"2010","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"ref95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000050657","article-title":"Prognostic parameters determining survival in pancreatic carcinoma and, in particular, after palliative treatment","volume":"19","author":"K Ridwelski","year":"2001","journal-title":"Dig Dis"},{"issue":"3","key":"ref96","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.lungcan.2011.05.009","article-title":"Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis","volume":"74","author":"I Gioulbasanis","year":"2011","journal-title":"Lung Cancer"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/1471-2407-11-489","article-title":"Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer","volume":"11","author":"JE Hwang","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"ref98","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13277-011-0237-7","article-title":"Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy","volume":"33","author":"N Kohles","year":"2012","journal-title":"Tumour Biol"},{"issue":"10","key":"ref99","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/jjco\/hys124","article-title":"Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer","volume":"42","author":"EC Hwang","year":"2012","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"ref100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SLA.0b013e3182602ad2","article-title":"Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy","volume":"256","author":"TC Chua","year":"2012","journal-title":"Ann Surg"},{"issue":"8","key":"ref101","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00520-011-1289-3","article-title":"Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer","volume":"20","author":"W Chua","year":"2012","journal-title":"Support Care Cancer"},{"issue":"3","key":"ref102","first-page":"301","article-title":"Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance","volume":"33","author":"CC Chang","year":"2010","journal-title":"Chang Gung Med J"},{"issue":"2","key":"ref103","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ijc.10343","article-title":"Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma","volume":"99","author":"H Nakanishi","year":"2002","journal-title":"Int J Cancer"},{"issue":"3","key":"ref104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000225621","article-title":"Prognostic significance of serum CRP levels and lymphoid cell infiltrates in human breast cancer","volume":"39","author":"RF Mortensen","year":"1982","journal-title":"Oncology"},{"issue":"2","key":"ref105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1464-410X.1990.tb14900.x","article-title":"Tumour markers as prognostic aids in prostatic carcinoma","volume":"66","author":"A Lewenhaupt","year":"1990","journal-title":"Br J Urol"},{"issue":"2","key":"ref106","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/02841869109092345","article-title":"Serum tumour markers in human prostatic carcinoma. The value of a marker panel for prognostic information","volume":"30","author":"P Ekman","year":"1991","journal-title":"Acta Oncol"},{"issue":"12","key":"ref107","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/0277-5379(85)90238-X","article-title":"The role of serum tumour markers to aid the selection of lung cancer patients for surgery and the assessment of prognosis","volume":"21","author":"T Muller","year":"1985","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"12","key":"ref108","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/bjs.5849","article-title":"Clinical prognostic scoring system to aid decision-making in gastro-oesophageal cancer","volume":"94","author":"DA Deans","year":"2007","journal-title":"Br J Surg"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-9-155","article-title":"Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer","volume":"9","author":"DK Kim","year":"2009","journal-title":"BMC Cancer"},{"issue":"2","key":"ref110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10238-010-0114-5","article-title":"Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19\u20139) in gastric cancer","volume":"11","author":"M Lukaszewicz-Zajac","year":"2011","journal-title":"Clin Exp Med"},{"issue":"3","key":"ref111","first-page":"589","article-title":"Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: response and survival","volume":"13","author":"SD Heys","year":"1998","journal-title":"Int J Oncol"},{"issue":"4","key":"ref112","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1385\/MO:22:4:353","article-title":"Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer","volume":"22","author":"F Tas","year":"2005","journal-title":"Med Oncol"},{"issue":"8","key":"ref113","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/annonc\/mdm138","article-title":"The B12\/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study","volume":"18","author":"L Kelly","year":"2007","journal-title":"Ann Oncol"},{"issue":"5","key":"ref114","first-page":"331","article-title":"Clinical predictors of survival in advanced cancer","volume":"3","author":"P Glare","year":"2005","journal-title":"J Support Oncol"},{"issue":"20","key":"ref115","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/jnci\/88.20.1456","article-title":"Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers","volume":"88","author":"DF Hayes","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"ref116","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/sonc.2002.32890","article-title":"Tumor markers as clinical cancer tests\u2014are we there yet?","volume":"29","author":"RL Schilsky","year":"2002","journal-title":"Semin Oncol"},{"issue":"8","key":"ref117","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ncponc0252","article-title":"REporting recommendations for tumor MARKer prognostic studies (REMARK)","volume":"2","author":"LM McShane","year":"2005","journal-title":"Nat Clin Pract Urol"},{"issue":"11","key":"ref118","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1158\/1055-9965.EPI-12-0611","article-title":"High-sensitivity C-reactive protein levels and cancer mortality","volume":"21","author":"YJ Ko","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"ref119","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/pcan.2011.5","article-title":"Presence of tumoural C-reactive protein correlates with progressive prostate cancer","volume":"14","author":"B Elsberger","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"7","key":"ref120","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00595-012-0147-3","article-title":"Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes","volume":"42","author":"T Nakatsu","year":"2012","journal-title":"Surg Today"},{"issue":"5","key":"ref121","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.eururo.2008.10.012","article-title":"Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma","volume":"55","author":"K Saito","year":"2009","journal-title":"Eur Urol"},{"issue":"2","key":"ref122","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.juro.2008.04.025","article-title":"Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy","volume":"180","author":"M Tatokoro","year":"2008","journal-title":"J Urol"},{"issue":"7","key":"ref123","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1245\/s10434-011-1575-9","article-title":"Association of C-reactive protein gene polymorphisms and colorectal cancer","volume":"18","author":"SH Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"ref124","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/ijc.25721","article-title":"Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival","volume":"128","author":"ML Slattery","year":"2011","journal-title":"Int J Cancer"},{"issue":"1","key":"ref125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00520-002-0390-z","article-title":"Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index","volume":"11","author":"D Walsh","year":"2003","journal-title":"Support Care Cancer"},{"issue":"8 Pt 2","key":"ref126","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1111\/j.1440-1746.2007.05105.x","article-title":"Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer","volume":"23","author":"AB Crumley","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"ref127","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.amjsurg.2011.10.015","article-title":"Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer","volume":"204","author":"S Dutta","year":"2012","journal-title":"Am J Surg"},{"key":"ref128","article-title":"Fuzzy Logic-Based Prognostic Score for Outcome Prediction in Esophageal Cancer","author":"CY Wang","year":"2012","journal-title":"IEEE Trans Inf Technol Biomed"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1186\/1471-2458-12-895","article-title":"Ability of a biomarker-based score to predict death from circulatory disease and cancer in NHANES III","volume":"12","author":"M Van Hemelrijck","year":"2012","journal-title":"BMC Public Health"},{"issue":"8","key":"ref130","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00384-006-0259-6","article-title":"Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer","volume":"22","author":"DC McMillan","year":"2007","journal-title":"Int J Colorectal Dis"},{"issue":"4","key":"ref131","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study","volume":"104","author":"MJ Proctor","year":"2011","journal-title":"Br J Cancer"},{"issue":"2","key":"ref132","doi-asserted-by":"crossref","first-page":"166 e17","DOI":"10.1016\/j.amjmed.2005.06.057","article-title":"What does minor elevation of C-reactive protein signify?","volume":"119","author":"I Kushner","year":"2006","journal-title":"Am J Med"},{"issue":"10","key":"ref133","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1248\/bpb.26.1494","article-title":"Levels of some acute-phase proteins in the serum of patients with cancer during radiotherapy","volume":"26","author":"M Koc","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"ref134","article-title":"An Introduction to Medical Statistics","author":"M Bland","year":"2002"},{"issue":"9","key":"ref135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/jech.2006.051292","article-title":"A systematic review of the association between circulating concentrations of C reactive protein and cancer","volume":"61","author":"K Heikkila","year":"2007","journal-title":"J Epidemiol Community Health"},{"issue":"9255","key":"ref136","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"F Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"2 Pt 2","key":"ref137","doi-asserted-by":"crossref","first-page":"733s","DOI":"10.1158\/1078-0432.CCR-06-2064","article-title":"Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang","volume":"13","author":"MS Ernstoff","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"5","key":"ref138","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/138945008784221206","article-title":"Cytokines: from gut inflammation to colorectal cancer","volume":"9","author":"MC Fantini","year":"2008","journal-title":"Curr Drug Targets"},{"issue":"1","key":"ref139","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2006.03.012","article-title":"Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer","volume":"53","author":"JM Jones","year":"2006","journal-title":"Lung Cancer"},{"issue":"6","key":"ref140","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"KC Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"ref141","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1373\/clinchem.2007.091959","article-title":"C-reactive protein and all-cause mortality in a large hospital-based cohort","volume":"54","author":"C Marsik","year":"2008","journal-title":"Clin Chem"},{"issue":"8","key":"ref142","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/sj.bjc.6604999","article-title":"Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond","volume":"100","author":"RD Riley","year":"2009","journal-title":"Br J Cancer"},{"issue":"5","key":"ref143","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1442-2042.1998.tb00380.x","article-title":"Significant prognostic factors for 5-year survival after curative resection of renal cell carcinoma","volume":"5","author":"H Masuda","year":"1998","journal-title":"Int J Urol"},{"issue":"11\u201312","key":"ref144","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/sj.bjc.6690277","article-title":"Prognostic impact of in vivo soluble cell adhesion molecules in metastatic renal cell carcinoma","volume":"79","author":"R Hoffmann","year":"1999","journal-title":"Br J Cancer"},{"issue":"6","key":"ref145","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjc.6603034","article-title":"The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer","volume":"94","author":"GW Lamb","year":"2006","journal-title":"Br J Cancer"},{"issue":"12","key":"ref146","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/sj.bjc.6603192","article-title":"An approach to estimating prognosis using fractional polynomials in metastatic renal carcinoma","volume":"94","author":"P Royston","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"ref147","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2006.06497.x","article-title":"Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma","volume":"99","author":"Y Komai","year":"2007","journal-title":"BJU Int"},{"issue":"2","key":"ref148","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cncr.22400","article-title":"Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer","volume":"109","author":"S Ramsey","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"ref149","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/cncr.22896","article-title":"C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients","volume":"110","author":"PI Karakiewicz","year":"2007","journal-title":"Cancer"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1479-5876-5-51","article-title":"Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors","volume":"5","author":"M Guida","year":"2007","journal-title":"J Transl Med"},{"issue":"4","key":"ref151","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1442-2042.2008.01990.x","article-title":"How do symptoms have an impact on the prognosis of renal cell carcinoma?","volume":"15","author":"N Kawata","year":"2008","journal-title":"Int J Urol"},{"issue":"3","key":"ref152","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.juro.2008.10.156","article-title":"Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score","volume":"181","author":"Y Iimura","year":"2009","journal-title":"J Urol"},{"issue":"5","key":"ref153","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.juro.2010.12.037","article-title":"Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors?","volume":"185","author":"H Kume","year":"2011","journal-title":"J Urol"},{"key":"ref154","article-title":"Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era?","author":"N Shinohara","year":"2011","journal-title":"Urol Oncol"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000327477","article-title":"The impact of preoperative serum albumin level and postoperative C-reactive protein nadir on the survival of patients with non-metastatic renal cell carcinoma with vessel thrombus after nephrectomy","volume":"5","author":"N Soga","year":"2011","journal-title":"Curr Urol"},{"issue":"2","key":"ref156","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bjc.2011.556","article-title":"Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems","volume":"106","author":"GW Lamb","year":"2012","journal-title":"Br J Cancer"},{"issue":"3","key":"ref157","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000334971","article-title":"Prospective study of the role of inflammation in renal cancer","volume":"88","author":"T Qayyum","year":"2012","journal-title":"Urol Int"},{"issue":"10","key":"ref158","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1442-2042.2012.03071.x","article-title":"C-reactive protein as a prognostic marker for advanced renal cell carcinoma treated with sunitinib","volume":"19","author":"T Fujita","year":"2012","journal-title":"Int J Urol"},{"key":"ref159","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.5_suppl.436","article-title":"Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors","author":"Y Yasuda","year":"2012","journal-title":"Int J Clin Oncol"},{"issue":"12","key":"ref160","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1442-2042.2012.03115.x","article-title":"Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy","volume":"19","author":"A Kawashima","year":"2012","journal-title":"Int J Urol"},{"issue":"11 Pt B","key":"ref161","doi-asserted-by":"crossref","first-page":"E771","DOI":"10.1111\/j.1464-410X.2012.11642.x","article-title":"Inflammatory prognostic markers in clear cell renal cell carcinoma\u2014preoperative C-reactive protein does not improve predictive accuracy","volume":"110","author":"J Bedke","year":"2012","journal-title":"BJU Int"},{"issue":"7","key":"ref162","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/bjc.2012.360","article-title":"Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma","volume":"107","author":"SH Sim","year":"2012","journal-title":"Br J Cancer"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/1471-2407-12-399","article-title":"Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients","volume":"12","author":"S Steffens","year":"2012","journal-title":"BMC Cancer"},{"issue":"4","key":"ref164","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0002-9610(98)00204-9","article-title":"Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer","volume":"176","author":"T Nozoe","year":"1998","journal-title":"Am J Surg"},{"issue":"8","key":"ref165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/BF02725342","article-title":"Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group","volume":"7","author":"HJ Nielsen","year":"2000","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"ref166","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/bjs.4038","article-title":"Systemic inflammatory response predicts survival following curative resection of colorectal cancer","volume":"90","author":"DC McMillan","year":"2003","journal-title":"Br J Surg"},{"issue":"4","key":"ref167","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/sj.bjc.6601156","article-title":"The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer","volume":"89","author":"DC McMillan","year":"2003","journal-title":"Br J Cancer"},{"issue":"6","key":"ref168","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1023\/B:DDAS.0000034556.48527.6e","article-title":"C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma","volume":"49","author":"C Miki","year":"2004","journal-title":"Dig Dis Sci"},{"issue":"9","key":"ref169","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.bjc.6601757","article-title":"Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer","volume":"90","author":"K Canna","year":"2004","journal-title":"Br J Cancer"},{"issue":"11","key":"ref170","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/00365520410009609","article-title":"Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor","volume":"39","author":"KP de Jong","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"ref171","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3748\/wjg.v11.i11.1639","article-title":"Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications","volume":"11","author":"NI Nikiteas","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"4","key":"ref172","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bjc.6602419","article-title":"The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer","volume":"92","author":"K Canna","year":"2005","journal-title":"Br J Cancer"},{"issue":"1","key":"ref173","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1207\/s15327914nc5501_10","article-title":"Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival","volume":"55","author":"JA Read","year":"2006","journal-title":"Nutr Cancer"},{"issue":"12","key":"ref174","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.bjc.6603185","article-title":"The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer","volume":"94","author":"JE Crozier","year":"2006","journal-title":"Br J Cancer"},{"issue":"7","key":"ref175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1463-1318.2007.01416.x","article-title":"The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer","volume":"10","author":"K Canna","year":"2008","journal-title":"Colorectal Dis"},{"issue":"9","key":"ref176","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/sj.bjc.6604027","article-title":"Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer","volume":"97","author":"EF Leitch","year":"2007","journal-title":"Br J Cancer"},{"issue":"5","key":"ref177","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/SLA.0b013e318142d964","article-title":"Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases","volume":"246","author":"HZ Malik","year":"2007","journal-title":"Ann Surg"},{"issue":"6","key":"ref178","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/SLA.0b013e3181454171","article-title":"Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer","volume":"246","author":"M Ishizuka","year":"2007","journal-title":"Ann Surg"},{"issue":"4","key":"ref179","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10350-007-9133-z","article-title":"Is C-reactive protein a prognostic factor of colorectal cancer?","volume":"51","author":"YC Shiu","year":"2008","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"ref180","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jso.21154","article-title":"Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer","volume":"98","author":"Y Koike","year":"2008","journal-title":"J Surg Oncol"},{"issue":"7","key":"ref181","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00595-007-3680-8","article-title":"Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma","volume":"38","author":"T Nozoe","year":"2008","journal-title":"Surg Today"},{"issue":"10","key":"ref182","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1515\/CCLM.2008.278","article-title":"Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients","volume":"46","author":"M Groblewska","year":"2008","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"ref183","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3816\/CCC.2008.n.044","article-title":"Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer","volume":"7","author":"R Sharma","year":"2008","journal-title":"Clin Colorectal Cancer"},{"issue":"4","key":"ref184","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjsurg.2007.12.052","article-title":"Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer","volume":"197","author":"JE Crozier","year":"2009","journal-title":"Am J Surg"},{"issue":"1","key":"ref185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jso.21294","article-title":"Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer","volume":"100","author":"M Ishizuka","year":"2009","journal-title":"J Surg Oncol"},{"issue":"11","key":"ref186","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s11605-009-1034-0","article-title":"The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers","volume":"13","author":"CS Roxburgh","year":"2009","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"ref187","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/SLA.0b013e3181b16e24","article-title":"Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer","volume":"250","author":"M Ishizuka","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"ref188","first-page":"653","article-title":"Predictors of survival in stage IV metastatic colorectal cancer","volume":"30","author":"M Zacharakis","year":"2010","journal-title":"Anticancer Res"},{"issue":"4","key":"ref189","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000280021","article-title":"Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival","volume":"27","author":"T Kobayashi","year":"2010","journal-title":"Dig Surg"},{"issue":"1","key":"ref190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6606005","article-title":"Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer","volume":"104","author":"E Volkova","year":"2011","journal-title":"Br J Cancer"},{"issue":"9","key":"ref191","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/sj.bjc.6605919","article-title":"The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer","volume":"103","author":"CH Richards","year":"2010","journal-title":"Br J Cancer"},{"issue":"1","key":"ref192","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/etm.2010.175","article-title":"Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer","volume":"2","author":"Y Toiyama","year":"2011","journal-title":"Exp Ther Med"},{"issue":"1","key":"ref193","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12192-010-0220-z","article-title":"High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer","volume":"16","author":"J Kocsis","year":"2011","journal-title":"Cell Stress Chaperones"},{"issue":"4","key":"ref194","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1245\/s10434-010-1410-8","article-title":"Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer","volume":"18","author":"CS Roxburgh","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"ref195","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/jso.23163","article-title":"Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer","volume":"106","author":"M Ishizuka","year":"2012","journal-title":"J Surg Oncol"},{"issue":"2","key":"ref196","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3892\/ol.2012.722","article-title":"The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases","volume":"4","author":"K Furukawa","year":"2012","journal-title":"Oncol Lett"},{"issue":"6","key":"ref197","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000346002","article-title":"Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer","volume":"29","author":"K Sugimoto","year":"2012","journal-title":"Dig Surg"},{"issue":"2","key":"ref198","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.sla.0000080822.22415.cb","article-title":"Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma","volume":"238","author":"M Ikeda","year":"2003","journal-title":"Ann Surg"},{"issue":"4","key":"ref199","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jso.10275","article-title":"Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma","volume":"83","author":"H Shimada","year":"2003","journal-title":"J Surg Oncol"},{"issue":"3","key":"ref200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1442-2050.2005.00474.x","article-title":"Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer","volume":"18","author":"P Guillem","year":"2005","journal-title":"Dis Esophagus"},{"issue":"23","key":"ref201","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.3748\/wjg.v12.i23.3746","article-title":"Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus","volume":"12","author":"I Gockel","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"11","key":"ref202","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/sj.bjc.6603150","article-title":"An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer","volume":"94","author":"AB Crumley","year":"2006","journal-title":"Br J Cancer"},{"issue":"5","key":"ref203","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.surg.2008.08.015","article-title":"Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma","volume":"144","author":"T Kobayashi","year":"2008","journal-title":"Surgery"},{"issue":"2","key":"ref204","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2009.01.002","article-title":"Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy","volume":"92","author":"CY Wang","year":"2009","journal-title":"Radiother Oncol"},{"issue":"3","key":"ref205","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000276910","article-title":"Inflammation-based prognostic score and number of lymph node metastases are independent prognostic factors in esophageal squamous cell carcinoma","volume":"27","author":"T Kobayashi","year":"2010","journal-title":"Dig Surg"},{"issue":"1","key":"ref206","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jso.21751","article-title":"Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer","volume":"103","author":"H Fujiwara","year":"2011","journal-title":"J Surg Oncol"},{"issue":"4","key":"ref207","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1245\/s10434-010-1383-7","article-title":"Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer","volume":"18","author":"YK Vashist","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"ref208","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00268-011-1130-7","article-title":"Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer","volume":"35","author":"S Dutta","year":"2011","journal-title":"World J Surg"},{"issue":"4","key":"ref209","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/bjc.2011.610","article-title":"The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma","volume":"106","author":"S Dutta","year":"2012","journal-title":"Br J Cancer"},{"issue":"11","key":"ref210","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/sj.bjc.6603446","article-title":"Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer","volume":"95","author":"DA Deans","year":"2006","journal-title":"Br J Cancer"},{"issue":"3","key":"ref211","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/bjc.1982.66","article-title":"Plasma protein profiles and prognosis in gastric cancer","volume":"45","author":"SA Rashid","year":"1982","journal-title":"Br J Cancer"},{"issue":"5","key":"ref212","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11605-010-1162-6","article-title":"Comparison of pre-treatment clinical prognostic factors in patients with gastro-oesophageal cancer and proposal of a new staging system","volume":"14","author":"AB Crumley","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1245\/s10434-011-1658-7","article-title":"Interrelationship between tumor proliferation activity, leucocyte and macrophage infiltration, systemic inflammatory response and survival in patients selected for potentially curative resection","volume":"18","author":"ABC Crumley","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"ref214","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/bjc.1983.198","article-title":"Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer","volume":"48","author":"J de Mello","year":"1983","journal-title":"Br J Cancer"},{"issue":"10","key":"ref215","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s00268-010-0641-y","article-title":"Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer?","volume":"34","author":"AB Crumley","year":"2010","journal-title":"World J Surg"},{"issue":"4","key":"ref216","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00595-009-4297-x","article-title":"Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer","volume":"41","author":"T Nozoe","year":"2011","journal-title":"Surg Today"},{"issue":"2","key":"ref217","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.amjsurg.2010.01.030","article-title":"Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma","volume":"201","author":"T Nozoe","year":"2011","journal-title":"Am J Surg"},{"issue":"1","key":"ref218","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10147-010-0135-9","article-title":"Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective study","volume":"16","author":"S Iwasa","year":"2011","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"ref219","first-page":"491","article-title":"C-reactive protein is a potential prognostic factor for metastatic gastric cancer","volume":"32","author":"T Shimura","year":"2012","journal-title":"Anticancer Res"},{"issue":"2","key":"ref220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/bjc.2012.262","article-title":"Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer","volume":"107","author":"X Jiang","year":"2012","journal-title":"Br J Cancer"},{"issue":"4","key":"ref221","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000341346","article-title":"Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy","volume":"83","author":"C Kunisaki","year":"2012","journal-title":"Oncology"},{"issue":"5","key":"ref222","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000342376","article-title":"Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer","volume":"83","author":"JH Jeong","year":"2012","journal-title":"Oncology"},{"issue":"1","key":"ref223","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1207\/S15327914NC3701_4","article-title":"Prognostic factors in advanced gastrointestinal cancer patients with weight loss","volume":"37","author":"P O'Gorman","year":"2000","journal-title":"Nutr Cancer"},{"issue":"2","key":"ref224","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1207\/s15327914nc4802_6","article-title":"Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer","volume":"48","author":"MM Elahi","year":"2004","journal-title":"Nutr Cancer"},{"issue":"4","key":"ref225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0002-9610(99)80296-7","article-title":"A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery","volume":"170","author":"DC McMillan","year":"1995","journal-title":"Am J Surg"},{"issue":"1","key":"ref226","first-page":"91","article-title":"The value of serum C-reactive protein, carcinoembryonic antigen and cancer-associated antigen 19.9 as prognostic factors for recurrence in colorectal cancer","volume":"6","author":"EK Kara","year":"2001","journal-title":"Journal of B U On"},{"issue":"1","key":"ref227","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1067\/msy.2003.31","article-title":"Treatment response and prognosis of patients after recurrence of esophageal cancer","volume":"133","author":"H Shimada","year":"2003","journal-title":"Surgery"},{"issue":"10","key":"ref228","first-page":"4581","article-title":"Inflammation-based prognostic score as a predictor of postoperative gastric cancer recurrence","volume":"32","author":"Y Mohri","year":"2012","journal-title":"Anticancer Res"},{"issue":"2","key":"ref229","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2249.1995.tb05524.x","article-title":"Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer","volume":"99","author":"WG Simpson","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"ref230","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1442-2042.2009.02289.x","article-title":"Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens","volume":"16","author":"H Miyake","year":"2009","journal-title":"Int J Urol"},{"issue":"3","key":"ref231","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.juro.2010.05.028","article-title":"Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma","volume":"184","author":"Y Ohno","year":"2010","journal-title":"J Urol"},{"issue":"4","key":"ref232","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3177\/jnsv.56.222","article-title":"Serum retinol, alpha-tocopherol and systemic inflammatory response in metastatic colorectal carcinoma patients treated with combination chemotherapy and cetuximab","volume":"56","author":"B Melichar","year":"2010","journal-title":"Journal of nutritional science and vitaminology"},{"issue":"11","key":"ref233","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1245\/s10434-012-2384-5","article-title":"Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen","volume":"19","author":"M Ishizuka","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"ref234","first-page":"665","article-title":"Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer","volume":"31","author":"S Wilop","year":"2008","journal-title":"Onkologie"},{"issue":"5","key":"ref235","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.urology.2011.11.070","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy","volume":"79","author":"T Gondo","year":"2012","journal-title":"Urology"},{"issue":"2","key":"ref236","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.amjsurg.2007.02.026","article-title":"Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas","volume":"195","author":"MW Muller","year":"2008","journal-title":"Am J Surg"},{"issue":"3","key":"ref237","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00520-010-0832-y","article-title":"Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer","volume":"19","author":"RJ Skipworth","year":"2011","journal-title":"Support Care Cancer"},{"issue":"11","key":"ref238","first-page":"5121","article-title":"Prognostic factors of unresectable pancreatic cancer treated with nafamostat mesilate combined with gemcitabine chemotherapy","volume":"32","author":"K Furukawa","year":"2012","journal-title":"Anticancer Res"},{"issue":"1","key":"ref239","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00520-012-1505-9","article-title":"Chemotherapy in patients with advanced pancreatic cancer: too close to death?","volume":"21","author":"M Frigeri","year":"2013","journal-title":"Support Care Cancer"},{"issue":"5","key":"ref240","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/MPA.0b013e31823bcc7b","article-title":"External validation of 2 prognostic indices for patients with advanced pancreatic cancer treated with first-line therapy","volume":"41","author":"M Haas","year":"2012","journal-title":"Pancreas"},{"issue":"5","key":"ref241","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1007\/s12032-012-0226-8","article-title":"Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer","volume":"29","author":"DS Wang","year":"2012","journal-title":"Med Oncol"},{"issue":"1","key":"ref242","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejogrb.2009.12.027","article-title":"The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer","volume":"149","author":"K Hefler-Frischmuth","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"ref243","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s12032-011-0045-3","article-title":"Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma","volume":"29","author":"M Grimm","year":"2012","journal-title":"Med Oncol"},{"issue":"3","key":"ref244","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3349\/ymj.2008.49.3.451","article-title":"A comprehensive prognostic stratification for patients with metastatic renal clear cell carcinoma","volume":"49","author":"KS Cho","year":"2008","journal-title":"Yonsei medical journal"},{"issue":"6","key":"ref245","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/01635581.2011.594207","article-title":"Prognostic significance of body mass index in Asian patients with localized renal cell carcinoma","volume":"63","author":"K Komura","year":"2011","journal-title":"Nutr Cancer"},{"issue":"8","key":"ref246","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/bjc.2011.368","article-title":"Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma","volume":"105","author":"K Hotta","year":"2011","journal-title":"Br J Cancer"},{"issue":"11b","key":"ref247","doi-asserted-by":"crossref","first-page":"E553","DOI":"10.1111\/j.1464-410X.2012.11246.x","article-title":"Late recurrence of renal cell carcinoma&gt; 5 years after surgery: clinicopathological characteristics and prognosis","volume":"110","author":"YH Park","year":"2012","journal-title":"BJU international"},{"issue":"2","key":"ref248","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10120-009-0509-8","article-title":"Serum interleukin-6 and -10 levels in patients with gastric cancer","volume":"12","author":"M Ikeguchi","year":"2009","journal-title":"Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association"},{"issue":"6","key":"ref249","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1442-2050.2008.00935.x","article-title":"Efficacy of chemoradiotherapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus","volume":"22","author":"R Takagawa","year":"2009","journal-title":"Dis Esophagus"},{"issue":"1","key":"ref250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jss.2012.08.051","article-title":"Prognostic value of circulating cytokines for stage III colon cancer","volume":"182","author":"WS Lee","year":"2013","journal-title":"The Journal of surgical research"},{"issue":"34","key":"ref251","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.3748\/wjg.v18.i34.4744","article-title":"Clinicopathologic significance of expression of nuclear factor-kappaB RelA and its target gene products in gastric cancer patients","volume":"18","author":"HC Kwon","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"4","key":"ref252","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s00268-011-0984-z","article-title":"Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma","volume":"35","author":"G Garcea","year":"2011","journal-title":"World J Surg"},{"issue":"2","key":"ref253","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00520-009-0639-x","article-title":"Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study","volume":"18","author":"SY Suh","year":"2010","journal-title":"Support Care Cancer"},{"issue":"2","key":"ref254","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejogrb.2007.02.020","article-title":"C-reactive protein serum levels are closely associated with lymph node status, but not with prognosis in patients with vulvar cancer","volume":"137","author":"L Six","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1758-3284-2-21","article-title":"C-reactive protein levels: a prognostic marker for patients with head and neck cancer?","volume":"2","author":"AL Kruse","year":"2010","journal-title":"Head & neck oncology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T04:22:03Z","timestamp":1653970923000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143080"}},"subtitle":[],"editor":[{"given":"Lanjing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,30]]},"references-count":255,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143080","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,30]]}}}